1Kitamura K, Kangawa K, Kawamoto Met al.Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun, 1993, 192:553-560.
2Sakata J, Shimokubo T, Kitamura K et al. Molecular cloning and biological activities of rat adrcnomedullin, a hypotensive peptide. Biochem Biophys Res Commun, 1993, 195:921 -927.
3Ishimitsu T, Kojima M, Kangawa K etal. Genomic structure of human Adrenomedullingene. Biochem Biophys Res Commun, 1994, 203 (1) : 631.
4Sugo S, Minanlno N, Kangawa K et al. Endothelial cells actively synthesize and secrate adrenornedullin. Biochem Biophys Res commun, 1994, 201 (3): 1160.
5Jougasaki M, Stevens TL, Borgeson DD et al. Adrenomedullin in experimental congestive heart failure: cardiorenal activation. Am J Physlol, 1997, 273:1392-1399.
6Juaneda. C, Dumont Y, Quirion R. The molecular pharmacology of CGRP and related peptlde receptor subtypes. Trend Pharmacol Sci, 2000, 21 (11): 432.
7McLachie LM, Fraser N J, Main MJ et al. RAMPs regulate the transport and ligand specificity of the calcitonin - receptor - like receptor. Nature, 1998, 393 (6683): 333.
8Chakravarty PS, Uthar T, Coppock HA et al. CGRP and adremmedullion binding correlates with transcript levels the calcitonin receptor - like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissuses Br3 Pharmacol, 2000, 130 (1) : 189.
9Hinson JP, Kapas S, Smith DM. Adrenomedulin, a muhifunctional regulatory peptide. Endocrina, 1999, 21 (2) : 138.
10Martinez A, Vos M, Cuedez L et al. The effects of adrenomedullin overexpresslon in breast tumor cell J Natt Cancer Inst, 2002, 94 (16) : 1226.
二级参考文献14
1Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin:a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun, 1993,192:553-560.
2Satoh F, Takahashi K, Murakami O, et al. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma.J Clin EndocrinolMetab, 1995, 80:1750-1752.
3Martinez A, Miller M J, Unsworth E J, et al. Expression of adrenomedullin in normal human lung and in pulmonary tumors.Endocrinology, 1995, 136:4099-4105.
4Martinez A, Vos M, Guedez L, et al. The effects of adrenomedullin overexpression in breast tumor cells. J Natl Cancer Inst, 2002, 94:1226-1237.
5Calvo A, Abasolo I, Jimenez N, et al.Adrenomedullin and proadrenomedullin N-terminal 20 peptide in the normal prostate and in prostate carcinoma. Microsc Res Tech. 2002. 57:98-104.
6Oehler MK, NorburyC, Hague S, et al. Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth.Oncogene, 2001, 20:2937-2945.
7Mazzocchi G, Albertin G, Andreis PG, et al. Distribution,functional role, and signaling mechanism of adrenomedullin receptors in the rat adrenal gland. Peptides, 1999, 20:1479-1487.
8Kohno M, Yasunari K, Minami M, et al. Regulation of rat mesangial cell migration by platelet-derived growth factor,angiotensin Ⅱ,and adrenomedullin.J Am Soc Nephrol, 1999, 10:2495-2502.
9Parameswaran N, Nambi P, Brooks DP, et al. Regulation of glomerular mesangial cell proliferation in culture by adrenomedullin.EurJ Pharmacol, 1999, 372:85-95.
10Zudaire E,Martinez A,Cuttitta F.Adrenomedullin and cancer[J].Regul Pept,2003,112 (1～3):175.
